TFIID, a multisubunit protein comprised of TBP (TATA box-binding protein) and TAF II s (TBP-associated factors), has a central role in transcription initiation at class II promoters. TAF II s role as mediators of regulatory transcription factors, such as pRb and p53, and their involvement in signal transduction pathways suggest that some may participate in the control of cell proliferation and dierentiation: therefore, they could be considered potential protooncogenes or antioncogenes. With the aim of starting to analyse these potential roles, we have determined the genomic position of nine human TAF II genes (TAF II 250, TAF II 135, TAF II 100, TAF II 80,  TAF II 55, TAF II 43, TAF II 31, TAF II 28, TAF II 20/15) and of two previously unknown sequences related to TAF II 250 and TAF II 31, respectively. Except for those encoding TAF II 250 and TAF II 31, these genes are present in a single copy and, with the exclusion of those for TAF II 43 and TAF II 28 (both at 6p21), are localized in dierent segments of the genome. Indeed, six of them map to a chromosomal region commonly altered in speci®c neoplasias, which de®nes them as candidates for involvement in oncogenesis. Our experiments also demonstrate that TAF II transcripts are synthesized ubiquitously, mostly at low levels similar to those of TBP. Interestingly, the amount of the major mRNA species detected by TAF II 20/15 cDNA is higher, which suggests that the polypeptide it encodes may also perform functions independently of TFIID. TAF II isoforms, indicated by additional bands on Northern blots, may play a role in modulation of TFIID function. These data will be useful for analysing variations of TAF II mRNA phenotype during cell proliferation, dierentiation and development, both normal and pathological.
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Keywords: TAF II s; regulation of gene expression; signal transduction; cell proliferation and dierentiation; oncogenesis; Cancer Genome Anatomy Project Cell proliferation and dierentiation (including apoptosis, that is a de®ned type of dierentiation) are regulated by dynamic interactions between environment and the genome, that are mediated by signal transduction mechanisms (reviewed by Hill and Treisman, 1995) . An important component in the activation of nuclear target genes in these pathways is TFIID, a class II general factor that has an essential role in transcription initiation and genome expression. TFIID is a multisubunit protein comprised of TBP, the TATA box-binding protein, and a series of tightly associated polypeptides called TAF II s (reviewed by Burley and Roeder, 1996, by Roeder, 1996 and by Verrijzer and Tjian, 1996; Bertolotti et al., 1996; Dubrovskaya et al., 1996a ). TAF II s perform core promoter-speci®c functions but also serve as targets for gene-speci®c activators and repressors (reviewed by Burley and Roeder, 1996; Roeder, 1996; Verrijzer and Tjian, 1996; Tansey and Herr, 1997) . Accordingly, it may be hypothesized that they too play an active role in regulating cell proliferation, cell dierentiation and development and that some of them may be involved in oncogenesis and in other genetic diseases.
Genomics of TFIID
To begin verifying these hypotheses, we have analysed the genomic anatomy of Homo sapiens TFIID. The chromosomal localization of the human genes encoding nine of its TAF II subunits and of two sequences, related to TAF II 250 and TAF II 31 respectively, was determined by following the cosegregation of DNA restriction fragments, detected by cDNA probes (Table  1) , with speci®c human chromosomes in a large panel of human/mouse hybrid cell lines (Table 2) . In a few cases, subregional mapping was obtained by examining hybrid cell lines retaining human chromosomes with structural mutations, such as translocations and deletions (Table 2 ). Finally, we used our published FISH methodology (Purrello et al., 1994a (Purrello et al., ,b 1995 (Purrello et al., , 1996 to perform a series of in situ hybridizations to human metaphase and prometaphase chromosomes and to analyse their results (Table 3; Figure 1 ). Besides those listed in the table, no other site was signi®cantly labeled. In the experiments carried out by using as probes the cDNAs encoding TAF II 250 and TAF II 31, about 35 and 36% of total hybridization sites were localized at Xq13 and 5q12 whereas only 24 and 23% were at 9p13 and at 19q12, respectively. Given the large number of metaphases analysed, these dierences are signi®cant: accordingly, we conclude that the Xq13 and 5q12 loci encode the two cDNAs, whereas those localized at 9p13 and 19q12, respectively, are related sequences (Table 3) .
The results obtained allowed us to determine the previously unknown genomic localization of the human genes for TAF II Xq11-13 (Brown et al., 1989) to Xq13 and from 10q24-25.2 (Dubrovskaya et al., 1996b) to 10q24, respectively (Table 3) . Together with those previously published on TBP (Purrello et al., 1994a) and TAF II 30 (Scheer et al., 1996) , these data de®ne the genomics of TFIID and make its characterization more complete. Similar to other general transcription initiation factors (Purrello et al., 1994a (Purrello et al., ,b 1995 , most TAF II s are encoded by single copy genes that are located in dierent regions of the human genome (Tables 2 and 3 ; Figure 1 ). This dispersion and the absence of clustering suggest that TFIID has evolved by accretion, that is by recruitment of new, phylogenetically unrelated, subunits based on their ability to interact with an extant protein core and to improve its biological function (Purrello et al., 1994a) . The co-localization of both TAF II 43 and TAF II 28 at 6p21 could be just the result of chance, given the absence of sequence homology between the two genes and of structural similarity between the polypeptides they encode (unpublished results).
TAF II s have been demonstrated to be mediators of upstream transcription factors, known to regulate cell TBP   TAF2A  TAF2A  TAF2C1  TAF2D  TAF2E  TAF2F  TAF2M  TAF2G  TAF2I  TAF2J pGEM7zf ( TAF2A  TAF2AL  TAF2C1  TAF2D  TAF2E  TAF2F  TAF2M  TAF2G  TAF2GL  TAF2I  TAF2J   243  243  116  60  54  56  161  62  62  135  136   531  531  276  126  106  152  187  96  96  217 Figure 1 FISH to human metaphase chromosomes of phTAF II 250 (a), phTAF II 31 (b) and phTAF II 28 (c). Both phTAF II 250 and phTAF II 31 detect two distinct loci, characterized by a dierent degree of homology to the probe. Based on the analysis of FISH signals distribution, we conclude that the loci encoding the two cDNAs are localized at Xq13 and 5q12, respectively: in fact, these ones are signi®cantly more labeled than the other two (Table 2) . Large and small arrows in panels A and B indicate the locus homologous and the one related to each cDNA probe, respectively. In situ hybridization to metaphase and prometaphase chromosomes from persons with normal karyotypes was done according to our published protocol (Purrello et al., 1994a) . Both entire plasmids and puri®ed inserts were used as probes at concentrations ranging from 400 nanograms/ml (for plasmid DNA) to 800 ± 1200 nanograms/ml (for inserts) proliferation and dierentiation (reviewed by Burley and Roeder, 1996; Roeder, 1996; Verrijzer and Tjian, 1996; Tansey and Herr, 1997) . TAF II 250, originally identi®ed as CCG1 (cell cycle G1 protein), is necessary for cells to progress through the G1 phase of the cycle and enter S-phase (Sekigushi et al., 1991) , and a speci®c ts mutation has been shown to directly and selectively aect transcription of the protooncogene cyclin D1 (Suzuki and Roeder, 1997) . TAF II 250 is also a potential target of Rb, which may modulate its regulatory eects on TBP (Kokubo et al., 1994; Shao et al., 1997) . TAF II 80 and TAF II 31 are coactivators of p53 and mediate its interactions with the general transcription apparatus Lu and Levine, 1995; Thut et al., 1995) : thus, it may be hypothesized that their mutations could at least in part mimic those of p53. Finally, Drosophila orthologs of human TAF II 135 and TAF II 80 are necessary for Bicoid to activate transcription of segmentation genes, whose expression is critical for establishing the body plan (Sauer et al., 1996) . These data suggest that TAF II s themselves could play a role in the control of cell proliferation, dierentiation and development. Accordingly, they may possibly be involved in oncogenesis and could be considered potential protooncogenes or antioncogenes for a candidate gene approach, based on our mapping data.
A list of human neoplasias, characterized by cytogenetically detectable mutations of the regions containing a TAF II locus, is reported in Table 4 , for which we utilized recently published data on the relationship between chromosomal rearrangements and tumors (Mitelman et al., 1997) . In the Table also are indicated the frequency of each mutation (i.e. number of specimens of the neoplasia with cytogenetically detectable mutations of the chromosomal regions of interest/total number of specimens of the neoplasia analysed) and its incidence (i.e. number of cytogenetically detectable mutations of the speci®c chromosomal region in a de®ned type of neoplasia/total number of cytogenetically detectable mutations identi®ed in the same type of neoplasia), which we calculated by using the data referred to previously (Mitelman et al., 1997) . Only mutations with a frequency equal to or higher than 5% were included in the Table. The molecular pathogenesis of all of these neoplasms is still uncharacterized, with the exception of lung hamartoma: in fact, the HMG1 genes (such as HMG1-Y, localized at 6p21) have been shown to be rearranged in these tumors and very likely are etiologically involved (Kazmierczak et al., 1996; Xiao et al., 1997) . On the other hand, the molecular events underlying initiation and progression of prostate adenocarcinoma (the second leading cause of male cancer death in the USA) are by large still unknown. A gene (PAC 1) from 6p21 has been recently demonstrated to be involved in causing apoptosis and suppressing the neoplastic phenotype of prostate adenocarcinoma cells, but its actual role in the disease is still undetermined (Sanchez et al., 1996) . This makes interesting our localization of TAF II 100 and TAF II 80 genes at 10q24 and at 7q22, respectively, since prostate tumor cells have frequently cytogenetically detectable mutations of these two regions (Table 4) : based on these data, both TAF II s may be considered as candidates for involvement in the pathogenesis of this neoplasia.
Northern analysis of TAF II transcripts
To start examining how the expression of TAF II genes varies during cell proliferation, dierentiation, development and in disease states such as neoplasia, we have determined the steady state TAF II mRNA phenotype (i.e. number, length and amount of dierent mRNA molecules) in Homo sapiens and in Rattus norvegicus. Northern analysis of RNA from two human cell lines, K562 and U937, demonstrated that the pattern of TAF II mRNA species synthesized in both was identical at all of the loci studied and remained unaltered after switching the hybridization stringency from high to low. Also, no variation of TAF II mRNA phenotype was found in the dierent murine organs analysed (Figure 2) . By using as probes the cDNAs listed in Table 1 , we demonstrated that TAF II genes are transcribed ubiquitously at low levels, similar to those of TBP: in fact, trancripts for these polypeptides were detected in the two human lines and in rat cerebrum, heart, small intestine, kidney, liver, { } Incidence is the number of cytogenetically detectable mutations of a speci®c chromosomal region in a de®ned type of neoplasia/total number of cytogenetically detectable mutations identi®ed in the same type of neoplasia lung, spleen, testis and uterus (Table 5) . Similar data on TAF II 55 have been published by another group (Lavigne et al., 1996) . The widespread transcription of TAF II genes is not totally unexpected, given that the polypeptides they encode are essential for viability in yeast and likely in all metazoans (reviewed by Tansey and Herr, 1997) .
In Homo sapiens, the cDNAs encoding TAF II 250, TAF II 80 and TAF II 55 identi®ed single mRNA species, whereas all of the other TAF II cDNAs detected more than one band (Table 5 ; Figure 2a ,b, and e). Besides TAF II 20/15 cDNA, also TAF II 80, TAF II 31 and possibly TAF II 55 cDNAs identi®ed multiple mRNA populations on Northern blots with murine RNA (Table 5) . As a rule, in all of these cases a major mRNA form could be identi®ed (Table 5 ; Figure 2a,b,c and e) . Interestingly, the amount of the major mRNA species hybridizing to TAF II 20/15 cDNA was reproducibly shown by densitometric analysis of Northern blots to be about 30 times higher than that of other TAF II s and TBP, both in Homo sapiens and Rattus norvegicus. Also very high was the amount of other ®ve transcripts detected by the same probe in both species (Figure 2a ,b and c).
Since we have demonstrated that, with the exclusion of those for TAF II 250 and TAF II 31, TAF II genes are present in a single copy in the human genome (Tables 2  and 3) , we conclude that the dierent human mRNA species detected by TAF II 100, TAF II 43, TAF II 28 and TAF II 20/15 cDNAs likely encode TAF II isoforms (Figure 2a,b and e) . Their synthesis would represent another mechanism for modifying TFIID structure and function, besides post-translation modi®cations of TBP and TAF II s (Boyer and Berk, 1993; Segil et al., 1996) and the selective addition of cell-and promoter-speci®c subunits (Jacq et al., 1994; Bertolotti et al., 1996; Dikstein et al., 1996) . Less likely, they could be mRNA molecules with a dierent primary structure but sharing a common motif, as hypothesized for the various transcripts detected by the 5' segment of TBP cDNA (Purrello et al., 1994a, and unpublished results) . The identi®cation of genomic sequences related to TAF II 250 and TAF II 31 adds to this functional complexity, since at least the one related to TAF II 31 could be a gene: in fact, the minor mRNA species detected by the relative cDNA could be transcribed from the 19q12 locus (Tables 3 and 5 ). If, as we propose, the dierent mRNA populations detected by TAF II 20/15 cDNA are true isoforms (one of them should encode TAF II 15) and are translated into comparable amounts of protein, there would be an imbalance between the synthesis of this TAF II and that of the others; this could be explained by hypothesizing that TAF II 20 and isoforms also perform functions independently of TFIID, either as single polypeptides or as subunits of other complexes. Something similar has been already described for the cyclin-dependent kinase-activating kinase (CAK), a heterotrimer comprised of cdk7, cyclin H and MAT-1: CAK may exist as a free complex or be associated either with ERCC2 or with TFIIH (Drapkin et al., 1996) .
Conclusions
Our data on the genomics and transcription of TAF II genes may contribute to investigations on the mechanisms of cancer development and lead to identi®cation of new cancer genes, which are both among the aims of the recently announced Cancer Genome Anatomy Project (Strausberg et al., 1997) . In turn, these studies could further our understanding of the biological role of these proteins and help in clarifying the complex functional networks of which TAF II s seem to be important components.
